Evaluate SEPN stock safety — financial health, volatility, institutional backing, and risk factors.

What are the risks of investing in SEPN? | Glauxie AI

Q: What are the risks of investing in SEPN?

Septerna, Inc. (SEPN) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Jeffrey T. Finer. Septerna, Inc., a clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products candidates for the treatment of endocrinology, immunology... Employees: 70,000.

Q: How much debt does SEPN have?

Review SEPN total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Q: Is SEPN a good long-term investment?

Evaluate SEPN as a long-term investment using fundamental scores, growth metrics, and risk assessment.

What are the risks of investing in SEPN?

🦉

Septerna, Inc. (SEPN)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOJeffrey T. Finer

Septerna, Inc., a clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products candidates for the treatment of endocrinology, immunology and inflammation, and metabolic diseases. The company develops SEP-786, an oral small molecule...

Key Executives

Name	Title
Arthur Christopoulos BPHARM	Co-Founder and Member of Cross-Functional Scientific & Drug Discovery Advisory Board
Elizabeth Bhatt	President & Chief Operating Officer
George Xu	Senior Director of Corporate Development & Portfolio Strategy
Gilbert Labrucherie	Chief Financial Officer
Jae Kim FACC	Chief Medical Officer
Jeffrey T. Finer	Co-Founder, Chief Executive Officer & Director

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

SEPN Profile Financials

Is SEPN stock safe? How much debt does SEPN have? Is SEPN a good long-term investment?